Recent Finacing
Recent Raise
Quellis Biosciences is a Boston-based biotech developing novel monoclonal antibodies for a validated rare-disease mechanism, optimizing multiple Xtend Fc–licensed programs to extend antibody half-life and reduce dosing.
Focus Areas
Recent Investors
Total Raised
Funding round
Investor
See the team members at Quellis Biosciences.
